Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol + etomidate versus propofol alone for I-Gel laryngeal mask airway insertion under general anesthesia
TCTR20260114010Phase 3Completed
- Sponsor
- Kanittha Nakkarin
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of propofol, etomidate, sponsored by Kanittha Nakkarin. Started May 2025; status: completed.
02
Drugs
propofoletomidate
Beyond the preview
Go deeper on TCTR20260114010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260114010.